Oliver Politz
Impact in
- Immunology top 5%
- Immune cells in cancer
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- Immune Response and Inflammation
- Biotechnology top 2%
- Enzyme Production and Characterization
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 9
-
- Prostate Cancer Treatment and Research 5
- Advanced Breast Cancer Therapies 5
- Co-authors
- Sergij Goerdt (10 shared papers)Vitam Kodelja (5 shared papers)Kai Schledzewski (6 shared papers)Pierre Guillot (5 shared papers)Alexei Gratchev (5 shared papers)C. Müller (2 shared papers)Rainer Borriss (8 shared papers)Nahid Hakiy (4 shared papers)
- Journals
- Cancer Research (12 papers)European Journal of Biochemistry (4 papers)Molecular Cancer Therapeutics (3 papers)British Journal of Haematology (2 papers)FEBS Journal (2 papers)
- Partner nations
- GermanyUnited StatesSingapore
In The Last Decade
Oliver Politz
52 papers receiving 2.4k citations
Peers
Comparison fields: 5 of 107
- Immunology 801
- Biotechnology 256
- Immunology and Allergy 129
- Oncology 456
- Molecular Biology 1.0k
Countries citing papers authored by Oliver Politz
This map shows the geographic impact of Oliver Politz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Politz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Politz more than expected).
Fields of papers citing papers by Oliver Politz
This network shows the impact of papers produced by Oliver Politz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Politz. The network helps show where Oliver Politz may publish in the future.
Co-authors
The 25 scholars most cited alongside Oliver Politz, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 53 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 280 | |
| 2 | 2002 | 247 | |
| 3 | 2001 | 231 | |
| 4 | Alternative macrophage activation-associated CC-chemokine-1, a novel structural homologue of macrophage inflammatory protein-1 alpha with a Th2-associated expression pattern. | 1998 | 225 |
| 5 | 1998 | 201 | |
| 6 | 2002 | 181 | |
| 7 | 2007 | 127 | |
| 8 | 1995 | 98 | |
| 9 | 2004 | 90 | |
| 10 | 2019 | 72 | |
| 11 | 2016 | 66 | |
| 12 | 1998 | 66 | |
| 13 | 2000 | 59 | |
| 14 | 2004 | 56 | |
| 15 | 2016 | 51 | |
| 16 | 2001 | 37 | |
| 17 | 2023 | 32 | |
| 18 | 1993 | 32 | |
| 19 | 2000 | 28 | |
| 20 | 2020 | 20 |
About Oliver Politz
Oliver Politz is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Immunology, Oncology and Cancer Research, having authored 53 papers that have together received 2.4k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (9 papers), Enzyme Production and Characterization (7 papers), Biofuel production and bioconversion (7 papers), Lymphoma Diagnosis and Treatment (6 papers), Chronic Lymphocytic Leukemia Research (5 papers), Prostate Cancer Treatment and Research (5 papers), Advanced Breast Cancer Therapies (5 papers) and Immune Response and Inflammation (4 papers). The work is most often cited by research in Immunology (801 citations), Biotechnology (256 citations), Immunology and Allergy (129 citations), Oncology (456 citations) and Molecular Biology (1.0k citations). Oliver Politz has collaborated with scholars based in Germany, United States and Singapore. Frequent co-authors include Sergij Goerdt, Vitam Kodelja, Kai Schledzewski, Pierre Guillot, Alexei Gratchev, C. Müller, Rainer Borriss, Nahid Hakiy, Bernard Haendler and C.E. Orfanos. Their work appears in journals such as Cancer Research, European Journal of Biochemistry, Molecular Cancer Therapeutics, British Journal of Haematology and FEBS Journal.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.